Photocure has reached agreement with BioSyent Pharma to reacquire the marketing and distribution rights to Cysview in Canada. The parties entered into a final agreement, stipulating that commercial rights will transfer to Photocure on January 1st, 2022. The reacquisition of marketing and distribuAlready a subscriber Login You have read all…